DAPAGLIFLOZIN

Product NDC
62332-393
11-digit product format
623320393
Labeler code
62332
Product ID
62332-393_befb2492-ced0-4523-9051-6d766b2fdb69
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
DAPAGLIFLOZIN
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Alembic Pharmaceuticals Inc.
Application
ANDA211560
Marketing category
ANDA
Marketing start
2026-04-06
Substance
DAPAGLIFLOZIN
Active strength
10 mg/1
Pharmacologic classes
Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

openFDA Listing Details

Product ID
62332-393_befb2492-ced0-4523-9051-6d766b2fdb69
SPL ID
befb2492-ced0-4523-9051-6d766b2fdb69
Product type
HUMAN PRESCRIPTION DRUG
Finished product
Yes
Brand name base
DAPAGLIFLOZIN
Generic name
DAPAGLIFLOZIN
Dosage form
TABLET, FILM COATED
Route
ORAL
Marketing start
2026-04-06
Marketing category
ANDA
Application number
ANDA211560
Pharmacologic classes
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
Listing expiration
2027-12-31

openFDA Active Ingredients

IngredientStrength
DAPAGLIFLOZIN10 mg/1

openFDA Harmonized Identifiers

FieldValues
Unii1ULL0QJ8UC
Rxcui1488569, 1488574
Spl Set Id840e2146-2383-489b-bcc4-fecfe986685a
Manufacturer NameAlembic Pharmaceuticals Inc.

openFDA Package Details

Package NDCDescriptionMarketing startSample
62332-393-3030 TABLET, FILM COATED in 1 BOTTLE (62332-393-30)2026-04-06No
62332-393-911000 TABLET, FILM COATED in 1 BOTTLE (62332-393-91)2026-04-06No

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
1ULL0QJ8UCDAPAGLIFLOZIN461432-26-8DAPAGLIFLOZIN

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
62332-393-306233203933030 TABLET, FILM COATED in 1 BOTTLE (62332-393-30) 2026-04-06NoNoHistorical
62332-393-91623320393911000 TABLET, FILM COATED in 1 BOTTLE (62332-393-91) 2026-04-06NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
DAPAGLIFLOZINAlembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited2026-04-07Human Prescription Drug Label11